Tumor growth in LTX-315-treated and CD8+ T cell depleted mice was perhaps more rapid than in untreated mice, further suggesting that the rate at which tumors regrow following LTX-315 treatment depends at least in part on CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.